AUD 0.45
(-3.23%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | -366.76 Thousand AUD | -108.84% |
2023 | 4.14 Million AUD | 43.17% |
2022 | 2.89 Million AUD | 115.93% |
2021 | 1.34 Million AUD | 45.7% |
2020 | 920.9 Thousand AUD | 47.69% |
2019 | 623.53 Thousand AUD | -49.53% |
2018 | 1.23 Million AUD | 985.77% |
2017 | 113.78 Thousand AUD | -29.05% |
2016 | 160.36 Thousand AUD | 5774.07% |
2015 | 2730.00 AUD | -92.44% |
2014 | 36.12 Thousand AUD | 208.93% |
2013 | -33.16 Thousand AUD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 FY | -366.76 Thousand AUD | -108.84% |
2024 Q2 | 2.18 Million AUD | 0.0% |
2024 Q4 | -173.48 Thousand AUD | 0.0% |
2023 Q2 | -75.28 Thousand AUD | 0.0% |
2023 Q4 | 4.22 Million AUD | 0.0% |
2023 FY | 4.14 Million AUD | 43.17% |
2022 Q4 | 3 Million AUD | 0.0% |
2022 FY | 2.89 Million AUD | 115.93% |
2022 Q2 | -108.26 Thousand AUD | 0.0% |
2021 Q2 | 549.44 Thousand AUD | 0.0% |
2021 FY | 1.34 Million AUD | 45.7% |
2021 Q4 | 792.31 Thousand AUD | 0.0% |
2020 FY | 920.9 Thousand AUD | 47.69% |
2020 Q4 | -50.42 Thousand AUD | 0.0% |
2020 Q2 | 971.33 Thousand AUD | 0.0% |
2019 FY | 623.53 Thousand AUD | -49.53% |
2019 Q2 | 313.38 Thousand AUD | 0.0% |
2019 Q4 | -29.4 Thousand AUD | 0.0% |
2018 Q2 | 212.45 Thousand AUD | 0.0% |
2018 FY | 1.23 Million AUD | 985.77% |
2018 Q4 | 623.2 Thousand AUD | 0.0% |
2017 Q4 | -564.01 Thousand AUD | 0.0% |
2017 FY | 113.78 Thousand AUD | -29.05% |
2017 Q2 | -367.7 Thousand AUD | 0.0% |
2016 FY | 160.36 Thousand AUD | 5774.07% |
2016 Q4 | -136.2 Thousand AUD | 0.0% |
2016 Q2 | 80.19 Thousand AUD | 0.0% |
2015 Q3 | - AUD | 100.0% |
2015 FY | 2730.00 AUD | -92.44% |
2015 Q2 | -83.19 Thousand AUD | 0.0% |
2015 Q4 | 85.92 Thousand AUD | 0.0% |
2014 FY | 36.12 Thousand AUD | 208.93% |
2013 FY | -33.16 Thousand AUD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
EZZ Life Science Holdings Limited | 50.94 Million AUD | 100.72% |
Anatara Lifesciences Ltd | -748.91 Thousand AUD | 51.026% |
Zelira Therapeutics Limited | 10.28 Thousand AUD | 3666.394% |
Biome Australia Limited | 7.66 Million AUD | 104.782% |
Patrys Limited | 1.39 Million AUD | 126.307% |
Orthocell Limited | 3.68 Million AUD | 109.944% |
Imugene Limited | -5.83 Million AUD | 93.72% |
Noxopharm Limited | -534.81 Thousand AUD | 31.421% |
PYC Therapeutics Limited | 22.05 Million AUD | 101.663% |
Chimeric Therapeutics Limited | 7.45 Million AUD | 104.921% |
Prescient Therapeutics Limited | 3.71 Million AUD | 109.88% |
Proteomics International Laboratories Limited | -1.12 Million AUD | 67.346% |
Cynata Therapeutics Limited | 2.31 Million AUD | 115.839% |
CSL Limited | 15.28 Billion AUD | 100.002% |
Arovella Therapeutics Limited | -25.97 Thousand AUD | -1311.786% |
Bio-Gene Technology Limited | -301.44 Thousand AUD | -21.668% |
Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 100.47% |
Starpharma Holdings Limited | 7.65 Million AUD | 104.79% |
Nanollose Limited | -348.95 Thousand AUD | -5.106% |
Memphasys Limited | 1606.00 AUD | 22937.36% |
Invex Therapeutics Ltd | 1.21 Million AUD | 130.255% |
NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | -301.555% |
Amplia Therapeutics Limited | 4.01 Million AUD | 109.145% |
Botanix Pharmaceuticals Limited | -6.55 Million AUD | 94.402% |
Island Pharmaceuticals Limited | 1.25 Million AUD | 129.305% |
Race Oncology Limited | 1.38 Million AUD | 126.388% |
Nyrada Inc. | -5164.07 AUD | -7002.305% |
Telix Pharmaceuticals Limited | 308.5 Million AUD | 100.119% |
Dimerix Limited | 583.47 Thousand AUD | 162.859% |
PharmAust Limited | -1641.00 AUD | -22250.274% |
Immutep Limited | 1.44 Million AUD | 125.401% |
Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 103.187% |
Alterity Therapeutics Limited | 3.8 Million AUD | 109.639% |
BTC Health Limited | 16.36 Thousand AUD | 2341.858% |
Acrux Limited | -1.28 Million AUD | 71.436% |
Neuren Pharmaceuticals Limited | 205.17 Million AUD | 100.179% |
Biotron Limited | -40.49 Thousand AUD | -805.645% |
Tissue Repair Ltd | 150.51 Thousand AUD | 343.682% |
AdAlta Limited | 1.5 Million AUD | 124.323% |
Radiopharm Theranostics Limited | -21.3 Million AUD | 98.279% |
Hexima Limited | - AUD | Infinity% |
AnteoTech Limited | 460.39 Thousand AUD | 179.663% |
Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | 745.582% |
Avecho Biotechnology Limited | -43.79 Thousand AUD | -737.465% |
Actinogen Medical Limited | 9.93 Million AUD | 103.693% |
Immuron Limited | 3.33 Million AUD | 110.992% |
Argenica Therapeutics Limited | 2.59 Million AUD | 114.118% |